CO:MINDMED
MindMed
- Stock
Last Close
7.09
22/11 21:00
Market Cap
500.56M
Beta: -
Volume Today
1.02M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Aug '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 3.10M - | 3.14M 1.44% | 3.12M 0.67% | |||
average receivables | ||||||
book value per share | 7.22 - | 4.27 40.76% | 5.54 29.59% | 4.89 11.72% | 0.00 99.96% | |
capex per share | -0.83 - | |||||
capex to depreciation | -46.90 - | |||||
capex to operating cash flow | 1.51 - | |||||
capex to revenue | ||||||
cash per share | 0.05 - | 4.51 9,448.94% | 4.88 8.09% | 4.61 5.56% | 0.00 99.94% | |
days of inventory on hand | -0.00 - | |||||
days payables outstanding | ||||||
days sales outstanding | ||||||
debt to assets | 0.00 - | |||||
debt to equity | 0.00 - | |||||
dividend yield | ||||||
earnings yield | -4.17 - | -0.04 98.99% | -0.16 290.90% | -0.70 324.06% | -0.00 99.90% | |
enterprise value | 249.55K - | 731.88M 293,175.00% | 433.17M 40.81% | -74.18M 117.13% | 143.22B 193,156.81% | |
enterprise value over ebitda | -0.54 - | -22.16 3,997.68% | -4.62 79.15% | 1.00 121.59% | -1.53K 153,056.79% | |
ev to operating cash flow | -1.20 - | -31.02 2,486.60% | -9.45 69.52% | 1.48 115.65% | -2.23K 150,487.25% | |
ev to sales | ||||||
free cash flow per share | -1.37 - | -1.33 3.28% | -1.67 25.89% | -1.62 2.92% | -0.00 99.90% | |
free cash flow yield | -1.95 - | -0.03 98.51% | -0.08 178.24% | -0.74 813.39% | -0.00 99.94% | |
graham net net | -0.47 - | 4.19 997.99% | 4.43 5.55% | 3.99 9.91% | 0.00 99.97% | |
graham number | 21.85 - | 13.59 37.79% | 20.58 51.40% | 12.98 36.92% | 0.01 99.92% | |
income quality | 0.19 - | 0.70 272.79% | 0.49 29.16% | 0.88 79.23% | 0.67 23.84% | |
intangibles to total assets | 0 - | 0 | 0.16 Infinity% | 0.14 14.98% | 0.16 18.21% | |
interest coverage | -201.40 - | -268.42 33.28% | -44.37 83.47% | |||
interest debt per share | 0.01 - | 0.01 41.91% | 0.05 287.26% | |||
inventory turnover | -792.97K - | |||||
invested capital | 0.00 - | |||||
market cap | 267.48K - | 811.97M 303,458.53% | 566.71M 30.21% | 67.89M 88.02% | 143.32B 211,011.68% | |
net current asset value | 2.74M - | 75.87M 2,670.96% | 124.88M 64.60% | 126.98M 1.68% | 57.47M 54.74% | |
net debt to ebitda | 0.04 - | 2.42 6,141.06% | 1.42 41.26% | 1.91 34.11% | 1.06 44.40% | |
net income per share | -2.94 - | -1.92 34.67% | -3.40 76.87% | -1.53 54.93% | -0.00 99.84% | |
operating cash flow per share | -0.55 - | -1.33 142.38% | -1.67 25.89% | -1.62 2.92% | -0.00 99.90% | |
payables turnover | ||||||
receivables turnover | ||||||
research and ddevelopement to revenue | ||||||
return on tangible assets | -0.38 - | -0.42 10.11% | -0.68 62.08% | -0.32 52.38% | -0.92 184.85% | |
revenue per share | ||||||
roe | -0.41 - | -0.45 10.29% | -0.61 36.48% | -0.31 48.95% | -1.23 291.25% | |
roic | -0.17 - | -0.44 155.84% | -0.63 43.46% | -0.37 41.78% | -1.20 228.79% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | 7.22 - | 4.27 40.76% | 5.54 29.59% | 4.89 11.72% | 0.00 99.96% | |
stock based compensation to revenue | ||||||
tangible asset value | 2.74M - | 75.87M 2,670.96% | 124.88M 64.60% | 127.31M 1.95% | 57.69M 54.69% | |
tangible book value per share | 7.22 - | 4.27 40.76% | 4.56 6.71% | 4.13 9.55% | 0.00 99.96% | |
working capital | 2.74M - | 78.51M 2,767.49% | 126.81M 61.51% | 128.16M 1.07% | 71.63M 44.11% |
All numbers in USD (except ratios and percentages)